Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris

Current strategies for the prevention of angina in patients with stable coronary artery disease

“…The 16 mg dosing provided better 24-h protection from angina; however, hypotension was a side effect [65].…”

Conventional and Novel Drug Therapeutics to Relief Myocardial Ischemia

“…When compared with placebo, it reduced the incidence of anginal attacks, the use of sublingual nitrates, and increased exercise capacity in patients with stable angina [33,34]. Higher doses provided better protection from angina, although hypotension was a side effect [35]. This new drug is not yet in routine clinical use; however, it may serve as useful alternative or adjunct to conventional antianginal treatment.…”

Guía sobre el manejo de la angina estable. Versión resumida

“…Hasta la fecha no se ha determinado si estos fármacos influyen en el pronóstico de los pacientes con angina estable. La molsidomina es un vasodilatador con una acción similar a la de los nitratos orgánicos y, administrada en las dosis adecuadas, es un agente antiisquémico y antianginoso efectivo 217 . No se comercializa en todos los países.…”